This compound is a pharmaceutical intermediate specifically used in the manufacture of olaparib. It features a fluorinated aromatic ring and a piperazine carboxamide moiety, contributing to its role as a key building block in drug synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 763111-47-3
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
Pharmaceutical intermediate
4-{[4-fluoro-3-(4-nitrosopiperazine-1-carbonyl)phenyl]methyl}-1,2-dihydrophthalazin-1-one
nitrosamine impurity reference standard
Olaparib
Antineoplastic poly(ADP-ribose) polymerase inhibitor
Tert-Butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoyl)piperazine-1-carboxylate
Pharmaceutical intermediate
2-Fluoro-5-((3-oxoisobenzofuran-1(3H)-ylidene)methyl)benzonitrile
Pharmaceutical intermediate for Olaparib synthesis
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
Pharmaceutical intermediate for olaparib
3-amino-n-(tert-butoxycarbonyl)-d-alanine
Pharmaceutical intermediate for peptide synthesis
2-BUTYN-1-OL
pharmaceutical intermediate
4-[[4-fluoro-3-(piperazine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one
MFFUYEOGICAKCK-UHFFFAOYSA-N
C1CN(CCN1)C(=O)C2=C(C=CC(=C2)CC3=NNC(=O)C4=CC=CC=C43)F